Morgan Stanley Finance LLC has announced a new structured investment product through its recent SEC filing. The pricing supplement, designated as No. 19,347, outlines the terms for Contingent Income Memory Buffered Auto-Callable Securities due October 19, 2029. This development is significant as it showcases Morgan Stanley's commitment to expanding its product offerings in the competitive securities market.
Founded as a part of the larger Morgan Stanley entity, Morgan Stanley Finance LLC operates under the Standard Industrial Classification of 6211, which encompasses Security Brokers, Dealers & Flotation Companies. The company is incorporated in Delaware and has its business address at 1585 Broadway, New York, NY. The recent filing, dated October 20, 2026, is part of a series of filings that include several pricing supplements and other related documents.
The filing specifies that the new securities are contingent upon the performance of the iShares Silver Trust and the VanEck Gold Miners ETF. Investors in these securities will face risks, including the potential loss of principal, depending on the performance of the underlying assets. The securities are fully and unconditionally guaranteed by Morgan Stanley, which adds a layer of security for investors.
This new offering may impact a range of stakeholders, including retail investors looking for innovative investment options, as well as competitors in the securities industry. The filing indicates that the securities will not provide regular interest payments, which may appeal to a specific segment of investors willing to accept higher risks for potential rewards.
Looking ahead, further filings are expected as Morgan Stanley continues to roll out additional structured products. The company’s strategy appears focused on meeting diverse investor needs while navigating the complexities of the current financial landscape. For more details, the accession number for this filing is 0001839882-26-051678.
Read Next
Sunrun Inc. Amends Bylaws to Enhance Governance Practices
Bioxytran launches first two nutraceutical products
Ericsson announces share buyback program for November 2026
Ferrari announces share buyback as part of €3.5 billion program
American Express Reports Delinquency and Write-off Statistics
Novo Nordisk announces DKK 15 billion share repurchase plan










